quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:32:51·43d
SECFiling
Pliant Therapeutics Inc. logo

SEC Form S-8 filed by Pliant Therapeutics Inc.

PLRX· Pliant Therapeutics Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • PLRX
    Pliant Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Oct 10UpdateAnalyst-
  • Mar 4UpdateNeedham-
  • Mar 4UpdateCantor Fitzgerald-
  • Mar 3UpdateStifel-
  • Mar 3UpdateLeerink Partners-
  • Feb 10UpdateAnalyst-

Related

  • SEC1d
    SEC Form DEFA14A filed by Pliant Therapeutics Inc.
  • SEC1d
    SEC Form DEF 14A filed by Pliant Therapeutics Inc.
  • PR5d
    Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting
  • INSIDER6d
    SEC Form 4 filed by Kuo Minnie
  • INSIDER6d
    SEC Form 4 filed by Cummings Keith Lamont
  • INSIDER6d
    SEC Form 4 filed by Coulie Bernard
  • INSIDER6d
    SEC Form 4 filed by Cheung Lily
  • SEC6d
    Pliant Therapeutics Inc. filed SEC Form 8-K: Leadership Update
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022